AmerisourceBergen To Purchase All Drugs Directly From Manufacturers
This article was originally published in The Pink Sheet Daily
The wholesaler currently buys less than 0.5% of U.S-distributed drugs from the secondary wholesale market.
You may also be interested in...
As part of the agreement, the firm is required to enter “Wholesaler Safe Product Practice” agreement.
Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.